Toho Holdings Co., Ltd.
東邦ホールディングス株式会社
TOHO HOLDINGS CO., LTD. Alias
TOHO HOLDINGS CO.,LTD. Alias
1948-09-17
TYO
Japan
Pharmaceutical wholesale business
Dispensing pharmacy business
Pharmaceutical manufacturing and sales business
Others
〒104-0028 2-2-1 Yaesu, Chuo-ku, Tokyo Midtown Yaesu, Yaesu Central Tower 9F, Tokyo, Japan
Hiroshi Edahiro
10,649,000,000  (106 100 million)
193 people
7,675 people
Company name
Group Parent Subsidiary Customer Supplier Alliance Bank Shareholder
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group Customer
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group Customer
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group Customer
イシンファーマ株式会社
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group Subsidiary
パナソニックヘルスケアホールディングス株式会社(現 PHC ホールディングス株式会社)
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group

183 entries
DateDescription
1948 Founded Toho Pharmaceutical. Based on experience in pharmaceutical sales and medical book publishing during wartime, founder Yoshinori Matsutani established Toho Pharmaceutical shortly after the war. Capital of 300,000 yen, with a total of 7 employees, began selling pharmaceuticals.
1948-09 TOHO PHARMACEUTICAL is founded (capital was ¥300,000) to start pharmaceutical wholesaling to hospitals as a pharmaceutical selling company.
1949 Obtained approval as a general pharmaceutical sales business, established Osaka branch, and set up a factory in Bunkyo Ward, Tokyo, to start manufacturing clinical trial reagents.
1950 Received approval as a pharmaceutical manufacturer and began manufacturing pharmaceuticals.
1951 Shifted from subcontract manufacturing to in-house products, producing 20 items.
1952 Launched in-house product
1959 Sanakura Eiyaku (Ikebukuro, Toshima-ku, Tokyo) entered into a business alliance and participated in management.
1963 Market development is accelerating through the establishment of a section chief system.
1968 The new headquarters building was established in Daizawa, Setagaya Ward, and a central branch was set up. Celebrating the 20th anniversary.
1969 To optimize logistics, a system was introduced, and Fujitsu's electronic computers were adopted to systematize accounting and payroll processing.
1970 Established Tohoku Pharmaceutical and actively opened branches mainly in the Tokyo metropolitan area.
1971 Established the first branch in Tohoku, Koriyama Branch.
1976 Established Omori Branch.
1979 Due to the enforcement of the revised Pharmaceutical Affairs Law, industry restructuring accelerated, and our company overhauled its internal management system.
1980 Listed stocks as Tokyo OTC registered stocks and held a stock listing commemorative meeting.
1980-11 TOHO PHARMACEUTICAL listed on the OTC (over-the-counter) market.
1983 Introduced the first Order Entry System (MCA System).
1986 Released the first customer support system, an inventory management system.
1988 Established the Tokyo Block Distribution Center (later TBC Heiwajima) and separated the headquarters computer division to establish Toho System Service.
1990 Released the pharmaceutical inventory management system "CM-100MIRA".
1991 Released the pharmaceutical order inventory management terminal "CM-1000MIRA".
1991 With the transition to a new pricing system, prices are now determined by the wholesaler's responsibility.
1991 Established Saitama Distribution Center (later TBC Omiya) in Omiya City, Saitama Prefecture.
1991 Masanobu Matsutani assumed the position of President and CEO.
1992 Founded the pharmaceutical information magazine "Toho Pharmaceutical News" (later "ENIF Pharmaceutical News").
1993 45th Anniversary Commemoration Project.
1993 Launched the "MAXIS Project".
1993 Conducted CI (Corporate Identity) activities, established new training systems and facilities, strengthened internal communication, and engaged in social contribution activities.
1993 Training and recreational facility "Shion Karuizawa".
1995 Released the medical appointment reservation system "LXMATE".
1996 Merged with A-MEI and started operating the logistics hub TBC Higashi-Osaka in Higashi-Osaka City, Osaka Prefecture.
1996-04 Emei (Osaka) is merged with TOHO PHARMACEUTICAL.
1997 Released the pharmaceutical ordering terminal "ENIFmini".
1997 Released the hospital inventory management system "ENIFwin".
1998-01 Kamiya Yakuhin (Sano) is merged with TOHO PHARMACEUTICAL.
1998 Established OTC specialized logistics center TBC Sano in Sano City, Tochigi Prefecture.
1998 Released the prescription fax system "eniFAX" (later "ENI Pharmacy").
1998 Launched the member service "ENIFclub".
1998 Birth of pharmaceutical split sales, and established "PFP (Pharmacy For Pharmacies)" in Tokyo (later "PFP Daizawa").
1998-10 Nakanihon Yakugyo (Kofu) is merged with TOHO PHARMACEUTICAL.
1999 Established the Co-Creation Future Group.
1999 Takashi Matsutani assumed the position of President and CEO.
1999-10 Enters into business alliance with Shouei (Aomori).
2000-01 Dohritsu Yakuhin (Sapporo) is merged with TOHO PHARMACEUTICAL. (Business alliance since May 1999)
2000 Established a call center
2000 Released "LXMATE HeLios"
2000-02 Takes over test agent sales in Kumamoto from Tsuruhara Yoshii.
2000-03 Takes over prescription pharmaceutical sales in Okayama from KSK.
2000-10 SANUS (Hiroshima) becomes a wholly owned subsidiary and takes over pharmaceutical sales in Hiroshima and Okayama. Takes over sales from Oshima Yakuhin (Sapporo).
2001-03 Takes over prescription pharmaceutical sales in Gunma from Maruzen Yakuhin.
2001-10 Honma Toho (former Honma Yakuhin) becomes a partly owned subsidiary and takes over pharmaceutical sales in Niigata. (Business alliance since Mar 2000)
2002 Listed on the Second Section of the Tokyo Stock Exchange
2002-10 Tokai Toho (former Funabashi Yakuhin) becomes a partly owned subsidiary and takes over pharmaceutical sales in Shizuoka. (Business alliance since Apr 2000) Transfers pharmaceutical sales in Ibraki to Yamaguchi Toho (former Yamaguchi Yakuhin). Takes over pharmaceutical sales in Tochigi from Yamaguchi Toho. Transfers pharmaceutical sales in Aomori to Shouei. Takes over pharmaceutical sales in Akita from Shouei. Takes over pharmaceutical sales in Akita and Tochigi from ASUCOME.
2002-12 TOHO PHARMACEUTICAL listed on the Second Section of Tokyo Stock Exchange.
2003 Implemented MS support system (PDA)
2003 Released "Pharmacist Web Learning"
2003-04 Oagawa Toho (former Ogawa Yakuhin) becomes a partly owned subsidiary and takes over pharmaceutical sales in Gunma. (Business alliance since Sep 1999) Yamaguchi Toho (Ibaraki) becomes a partly owned subsidiary. (Business alliance since Sep 2001) Takes over medical equipment and test agent sales from ASUCOME.
2004 Introduced voice recognition system into the call center
2004 Designated on the First Section of the Tokyo Stock Exchange
2004 Completed new headquarters building in Setagaya-ku, Daizawa
2004 Established TBC Okayama (Okayama Prefecture, Okayama City) and TBC Sapporo Branch (Hokkaido, Sapporo)
2004 Fully acquired Yakushin as a subsidiary
2004-03 TOHO PHARMACEUTICAL listed on the First Section of Tokyo Stock Exchange.
2004-10 Enters into business alliance with FLET (Kanazawa). Takes over pharmaceutical sales in Saitama from Kurihara Bentendo. (Business alliance since Jan 2000)
2004-11 YAKUSHIN (Fukuoka) becomes a wholly owned subsidiary. (Business alliance since Aug 2001)
2005-01 Godo Toho (Osaka) becomes a wholly owned subsidiary and takes over pharmaceutical sales in Osaka and Hyogo.
2005 Made Toho Joint Company a subsidiary and transferred sales of pharmaceuticals in Osaka and Hyogo Prefectures
2005 Signed business alliance agreements with Hokuyaku, Vitalnet, Nabeyashi, Chukoku Pharmaceutical, KSK, and Astem
2005 Fully acquired Kinoshita Pharmaceutical
2005 Norio Hamada appointed as President and CEO
2005 Integrated Kinoshita Pharmaceutical into Toho Joint Company
2005 In March 2005, two new companies, Iwabuchi Pharmaceutical and OMEL, joined a seven-company alliance to establish a joint operating company called Ashi no Kai
2005-03 Enters into business alliance with HOKUYAKU (Sapporo), VITAL-NET (Sendai), Nabelin (Matsumoto), Nakakita Yakuhin (Nagoya), KSK (Osaka), ASTEM (Oita).
2005-04 Kinoshita Yakuhin (Nara) becomes a wholly owned subsidiary. (Business alliance since Jun 2001)
2005-06 Enters into business alliance with OHKI (Tokyo).
2005-09 The HEREON Group established.
2005-10 KOYO (Takamatsu) becomes a partly owned subsidiary. (Business alliance since Jul 2003)
2005-10 Kinoshita Yakuhin is merged with Godo toho.
2006 Developed and introduced sales support terminal "Meissa"
2006 Published "Direct Magazine Urara" (later "Karakoro")
2006 Fully acquired Yoshii Tsuruhara
2006 Integrated Tokai Toho into Toho Pharmaceutical
2006 Established TBC Tokyo in Ota Ward, Tokyo
2006-04 Tsuruhara Yoshii (Kumamoto) becomes a wholly owned subsidiary. (Business alliance since Jan 2001)
2006-10 Tokai Toho (Nagoya) is merged with TOHO PHARMACEUTICAL.
2007 Yakushin was merged into Tsuruhara Yoshii (new company name: Kyushu Toho)
2007 Kokubu, Oki, and Toho Pharmaceutical form a business alliance among three companies
2007 Invested in Kyushu Tong Group in Wuhan, China
2007 Released internet reservation system "SELENE"
2007-04 YAKUSHIN (Fukuoka) is merged with Tsuruhara Yoshii (Kumamoto) to establish Kyushu Toho.
2007-08 Enters into business alliance with OHKI (Tokyo) and KOKUBU (Tokyo).
2008-01 Mori Pharmaceutical (Miyazaki) becomes a wholly owned subsidiary. (Business alliance since Sep 2007)
2008-02 Honma Toho (Niigata) becomes a wholly owned subsidiary. (Becomes a subsidiary in Oct 2001)
2008-02 KOYO (Takamatsu) becomes a wholly owned subsidiary. (Becomes a subsidiary in Oct 2005)
2008-10 Yamaguchi Toho (Tsuchiura) becomes a wholly owned subsidiary. (Becomes a subsidiary in Apr 2003)
2008-10 Ogawa Toho (Takasaki) becomes a wholly owned subsidiary. (Becomes a subsidiary in Apr 2003)
2008-11 Sue Pharmaceutical (Midori) becomes a wholly owned subsidiary. (Business alliance since Apr 1987)
2008-11 Ethos (Tokyo) becomes a wholly owned subsidiary.
2009-02 Nagaoka Pharmaceutical (Nagaoka) becomes a wholly owned subsidiary. (Business alliance since Mar 1990)
2009-04 Shift to a pure holding company structure and change of the company name from TOHO PHARMACEUTICAL to TOHO HOLDINGS.
2009-10 Kyushu Toho (Kumamoto) is merged with Mori Pharmaceutical (Miyazaki) to establish Kyushu Toho.
2009-10 OMWELL (Hiroshima) becomes a wholly owned subsidiary.
2009-10 The Reorganization of Dispensing Pharmacy Business Companies.
2010-01 Fully owned subsidiary of Ascam Co., Ltd. (Headquarters: Sendai City)
2010-01 SANUS (Hiroshima) is merged with OMWELL(Hiroshima) to establish SAYWELL.
2010-02 Fully owned subsidiary of Ascam Co., Ltd. (Headquarters: Sendai City). Business alliance in October 2000.
2010-02 ASUCOME (Sendai) becomes a wholly owned subsidiary. (Business alliance since Oct 2000)
2010-05 Establishing a joint venture with Kyushu Tsushin Group, Hokubu Kyoso Pharmaceutical
2010-05 TOHO HOLDINGS has established Hubei Kyoso Pharmaceutical. (Joint venture company)
2010-06 Fully owned subsidiary of Okinawa Toho Co., Ltd. (Headquarters: Naha City)
2010-06 Okinawa Toho (Naha) becomes a wholly owned subsidiary.
2010-10 Merging with Ascam Co., Ltd.
2010-10 ASUCOME (Sendai) is merged with TOHO PHARMACEUTICAL.
2011-04 Fully owned subsidiary of Showei Co., Ltd. (Headquarters: Aomori City)
2011-04 Shouei (Aomori) becomes a wholly owned subsidiary.
2011-10 Fully owned subsidiary of Koizumi Pharmaceutical Co., Ltd. (Headquarters: Sendai City)
2011-10 Koizumi Yakuhin (Sendai) becomes a wholly owned subsidiary.
2012-01 Merging with Showei Co., Ltd.
2012-01 Shouei (Aomori) is merged with TOHO PHARMACEUTICAL.
2013-04 Establishing Orphan Trust Japan Co., Ltd.
2013-04 TOHO HOLDINGS has established Orphan Trust Japan.
2013-07 Merging with Koizumi Pharmaceutical Co., Ltd. (Headquarters: Sendai City)
2013-07 Fully owned subsidiary of Okinawa Sawai Pharmaceutical Co., Ltd. (Headquarters: Naha City)
2013-07 Koizumi Yakuhin (Sendai) is merged with TOHO PHARMACEUTICAL.
2013-07 Okinawa Sawai Pharmaceutical (Naha) becomes a wholly owned subsidiary.
2013-10 Merging Honma Toho Co., Ltd. (Headquarters: Niigata City), Yamaguchi Toho Co., Ltd. (Headquarters: Tsuchiura City), Ogawa Toho Co., Ltd. (Headquarters: Takasaki City), and Sue Pharmaceutical Co., Ltd. (Headquarters: Midori City)
2013-11 Integrating seven dispensing pharmacies (Tomoniti, Pharmasquare, Mirai, Nest, Jaspha, Japan Pharmacy, Yotsuba) into Toho Mirai Co., Ltd.
2013-11 Reorganization of Dispensing Pharmacy Business Companies (Japan Pharmacy, Yotsuba, Pharma Square, Mirai, Nest, and Jus-Pharma merge with Pharma Mirai)
2014-01 Merging Okinawa Toho Co., Ltd. (Headquarters: Nishihara Town, Nakagami District) and Okinawa Sawai Pharmaceutical Co., Ltd. (Headquarters: Naha City) into Okinawa Toho Co., Ltd.
2014-01 Okinawa Toho (Nakagami-gun) merges with Okinawa Sawai Pharmaceutical (Naha) to establish Okinawa Toho
2015-06 Transitioning to a business holding company system
2015-06 Shift to an operating holding company structure
2016-06 Transitioning to a company with the Audit and Supervisory Committee
2016-06 Shift to a company with audit and supervisory committee
2016-09 Yell Pharmaceuticals Co., Ltd. (Headquarters: Tokyo) becomes a wholly owned subsidiary
2016-09 Seven companies of the Taiyo Yakuhin Group become wholly owned subsidiaries
2016-09 Yell Pharmaceutical (Tokyo) becomes a wholly owned subsidiary
2016-09 Seven member companies of the Taiyo Yakuhin Group become wholly owned subsidiaries
2016-10 Taisho-do Co., Ltd. (Headquarters: Shiga) becomes a wholly owned subsidiary
2016-10 TAISHODO (Shiga) becomes a wholly owned subsidiary
2016-11 Yell Pharmaceuticals Co., Ltd. (Headquarters: Tokyo) changes its company name to Co-Creation Future Pharma Co., Ltd.
2016-11 Change of the company name from Yell Pharmaceutical to KYOSOMIRAI PHARMA (Tokyo).
2017-01 Nichinan Medic Co., Ltd. (Headquarters: Miyazaki) becomes a wholly owned subsidiary
2017-01 Emcom Kyushu Co., Ltd. (Headquarters: Fukuoka) becomes a wholly owned subsidiary
2017-01 Nippou Medic (Miyazaki) becomes a wholly owned subsidiary.
2017-01 MCOM kyushu (Fukuoka) becomes a wholly owned subsidiary.
2017-04 Godo Toho Co., Ltd. (Headquarters: Osaka) merges
2017-04 Godo Toho (Osaka) is merged with TOHO PHARMACEUTICAL.
2018-09 Seiler Co., Ltd. (Headquarters: Hiroshima), Co-Creation Future Yamaguchi Pharmaceuticals Co., Ltd. (Headquarters: Yamaguchi), and Co-Creation Future Hiroshima Pharmaceuticals Co., Ltd. (Headquarters: Hiroshima) merge to form Seiler Co., Ltd.
2018-09 Kyushu Toho Co., Ltd. (Headquarters: Fukuoka), Co-Creation Future Fukuoka Pharmaceuticals Co., Ltd. (Headquarters: Fukuoka), Co-Creation Future Oita Pharmaceuticals Co., Ltd. (Headquarters: Oita), Co-Creation Future Kumamoto Pharmaceuticals Co., Ltd. (Headquarters: Kumamoto), and Co-Creation Future Kagoshima Pharmaceuticals Co., Ltd. (Headquarters: Kagoshima) merge to form Kyushu Toho Co., Ltd.
2018-09 Okinawa Toho Co., Ltd. (Headquarters: Okinawa), and Co-Creation Future Okinawa Pharmaceuticals Co., Ltd. (Headquarters: Okinawa) merge to form Okinawa Toho Co., Ltd.
2018-09 SAYWELL (Hiroshima) is merged with Kyoso Mirai Yamaguchi Pharmaceutical (Yamaguchi) and Kyoso Mirai Hiroshima Pharmaceutical (Hiroshima) to establish SAYWELL.
2018-09 Kyushu Toho (Fukuoka) is merged with Kyoso Mirai Fukuoka Pharmaceutical (Fukuoka), Kyoso Mirai Oita Pharmaceutical (Oita), Kyoso Mirai Kumamoto Pharmaceutical (Kumamoto) and Kyoso Mirai Kagoshima Pharmaceutical (Kagoshima) to establish Kyushu Toho.
2018-09 Okinawa Toho (Okinawa) is merged with Kyoso Mirai Okinawa Pharmaceutical (Okinawa) to establish Okinawa Toho.
2018-10 Hokuriku Toho Co., Ltd. (renamed from Kyoei Pharmaceuticals Co., Ltd., Headquarters: Toyama) becomes a wholly owned subsidiary
2018-10 Hokuriku Toho (former KYOUEI DRUG WHOLESALERS, Toyama) becomes a wholly owned subsidiary.
2020 Opened "TBC DynaBase" in Ota Ward, Tokyo. Located inside the wide-area transportation base designated by Tokyo Metropolitan Government, a high-functionality logistics facility "DynaBase" on floors 2-5. Located inside the inner side of Ring Road No. 7, enabling smooth pharmaceutical supply during disasters through cooperation with administrative agencies.
2020 Started providing remote detailing services through collaboration with Entatch
2021 Transferred WILL Heiwajima to former TBC Tokyo and restarted as TBC WILL Shinagawa
2021 Released online medical consultation and medication guidance system "KAITOS"
2021 Merged three transportation companies and changed the trade name to "Kyoso Logistics"
2022 Transitioned to Tokyo Stock Exchange Prime Market
2022 Acquired part of AYM HD (currently: Ayumi Pharmaceutical HD) stock
2022 TBC Hokuriku is operational
2022 Developed temperature-controlled transport device "Salum FZ"
2022 Released FutureENIF-WEB
2022-04 Transition to the Tokyo Stock Exchange Prime Market
2022-04 TOHO HOLDINGS listed to the Prime Market in Tokyo Stock Exchange.
2023 Formulated "Creating the Next Generation" for 2023-2025
2023 Established a joint research lab in collaboration with the National Institute of Advanced Industrial Science and Technology
2023 Launched the Dai-Zawa Project and relocated headquarters functions to Yaesu Office (Tokyo Midtown Yaesu)
2023 Released Kyoso Future Pharmacy Kenkou Navi
2024 Developed an implementation plan based on the verification results of the Management Strategy Committee
2024 Integrated Hokuriku Toho into Toho Pharmaceutical
2024 Hiroshi Edahiro appointed as President and CEO/CFO
2024-04 Hokuriku Toho Co., Ltd. (Headquarters: Toyama) merges
2024-04 Hokuriku Toho (Toyama) is merged with TOHO PHARMACEUTICAL.
2025 Launch of specialty product home delivery service "L1MON"
2025 Release of standard and professional versions of "HeLios cloud"
2025 Established "Haneda Packaging Center" within the same facility as TBC DynaBase
2025 Entered into business alliance with Teijin Regenerate and Itochu Corporation to build a regenerative medicine ecosystem
2025 Established CVC fund "TOHO Ventures"
2026 Formulated medium-term management plan 2026-2028 "Soaring to the Next Generation"
+ Loaded when opened
2026-09-22 09:59 (Model: ggml-org/gpt-oss-20b )
↑